The human gut is home to trillions of bacteria that play vital roles in digestion, immunity, and overall health. When this ...
Johnson & Johnson said that its mid-stage study of icotrokinra, for the treatment of moderate to severe active ulcerative ...
The human gut is home to trillions of bacteria that play vital roles in digestion, immunity, and overall health.
OSE Immunotherapeutics Hosts KOL Webinar Post-ECCO on Lusvertikimab and the Future of IBDNANTES, France – March 6, 2025, 6:00pm CET - OSE ...
Teva's business is encountering headwinds, including declining U.S. generics revenue. Read what this biotech plans to do in ...
In patients with ulcerative colitis, vedolizumab outperformed infliximab as a second-line therapy following failure of ...
Chiu also noted that beyond intestinal diseases, this new drug shows promising potential for treating a range of other ...
Ozanimod showed a rapid onset of action and efficacy as extended induction therapy in patients with ulcerative colitis nonresponsive to biologics.
According to the National Institutes of Health, between 600,000 and 900,000 Americans have ulcerative colitis, a chronic ...
The FDA had approved Otulfi in September 2024 to treat Crohn’s disease, ulcerative colitis, psoriasis and active psoriatic arthritis. Information on pricing is not yet available.
Four biosimilars for Stelara have launched in the United States this year following legal settlements with the reference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback